The IASLC Latin America Conference on Lung Cancer 2023 (LALCA 2023) provides a unique opportunity for participants to attend lectures by international and local/regional experts on key advances in the science of treating, detecting, and preventing lung cancer and other thoracic malignancies.

This is a multidisciplinary program, and we invite all healthcare professionals involved in the management and treatment of people affected by lung cancer.  This conference allows an excellent opportunity to collaborate with thoracic oncology specialists based in Latin America.

Upon completion of this activity, the participants should be able to: 

• Apply evidence-based recommendations and clinical practice guidelines to diagnose and treat patients with lung cancer and other thoracic malignancies. 
• Describe scientific advances in lung cancer and other thoracic malignancies. 
• Synthesize research from clinical trials and translational studies to deepen knowledge within primary specialty area(s) and broaden knowledge of other specialties.

Program Co-Chairs: 

• Luis Ubillos, MD, PhD, Uruguay
• Mario Varangot, MD, Uruguay
• Clarissa Mathias, Brazil
• Carlos Barrios, MD, Brazil

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.